Merger expected to close in Q4 2025
Company: Core Scientific
What the later record shows
Outcome not yet confirmed
The latest passage on the CoreWeave deal (October 14, 2025) still only says it is expected to close in Q4 2025, and no passage says it closed or was terminated. In 2026 Core Scientific was still filing its own 10-Qs and making its own acquisitions, which suggests the deal did not close, but no passage states that outright.
“Expected to close in Q4 2025 Subject to approval by the affirmative vote of a majority of Core Scientific’s outstanding common shares”
2025-10-14 · core-scientific 8-K exhibit (ef20057150_ex99-1.htm) View cached copy (2026-09-28)Live source ↗
“The Acquisition is expected to close by early in the third quarter of 2026 , subject to the satisfaction or waiver of the closing conditions.”
2026-05-05 · Core Scientific 8-K filed 2026-05-06 View cached copy (2026-08-31)Live source ↗
Checked October 11, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
The CoreWeave acquisition of Core Scientific is expected to close in the fourth quarter of 2025. Closing is subject to customary conditions, including regulatory approval and approval by Core Scientific stockholders.
Source (primary)
core-scientific 8-K exhibit (d52423dex991.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-11)Live source ↗
Quote: “The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including regulatory approval and approval by Core Scientific stockholders.”
How we checked this
Checked on October 15, 2026. The cited source supports every part of this claim.
The release states the expected Q4 2025 close and the regulatory and Core Scientific stockholder approval conditions.
Confirmed in the source:
- The transaction is expected to close in the fourth quarter of 2025
- Closing is subject to customary closing conditions
- Conditions include regulatory approval
- Conditions include approval by Core Scientific stockholders
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312525155925/d52423dex991.htm) in full (19,368 characters, retrieved October 11, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d52423dex991.htm)
Quote: “The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including regulatory approval and approval by Core Scientific stockholders.”